Wells Fargo’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1
| Closed | -$5 | – | 7356 |
|
|
2025
Q3 | $5 | Hold |
1
| – | – | ﹤0.01% | 6934 |
|
|
2025
Q2 | $4 | Hold |
1
| – | – | ﹤0.01% | 7016 |
|
|
2025
Q1 | $4 | Hold |
1
| – | – | ﹤0.01% | 6903 |
|
|
2024
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 6962 |
|
|
2024
Q3 | $5 | Hold |
1
| – | – | ﹤0.01% | 6761 |
|
|
2024
Q2 | $6 | Sell |
1
-4
| -80% | -$27 | ﹤0.01% | 6712 |
|
|
2024
Q1 | $36 | Buy |
5
+1
| +25% | +$7 | ﹤0.01% | 6931 |
|
|
2023
Q4 | $37 | Hold |
4
| – | – | ﹤0.01% | 7010 |
|
|
2023
Q3 | $40 | Hold |
4
| – | – | ﹤0.01% | 6982 |
|
|
2023
Q2 | $54 | Hold |
4
| – | – | ﹤0.01% | 7037 |
|
|
2023
Q1 | $65 | Hold |
4
| – | – | ﹤0.01% | 7043 |
|
|
2022
Q4 | $60 | Hold |
4
| – | – | ﹤0.01% | 6954 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 7388 |
|
|
2022
Q2 | $0 | Buy |
4
+1
| +33% | +$12 | ﹤0.01% | 7505 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 7827 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 7818 |
|
|
2021
Q3 | $0 | Buy |
3
+1
| +50% | +$44 | ﹤0.01% | 7530 |
|
|
2021
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 7453 |
|
|
2021
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7385 |
|
|
2020
Q4 | $0 | Buy |
2
+1
| +100% | +$79 | ﹤0.01% | 7030 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6914 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6836 |
|
|
2020
Q1 | $0 | Buy |
+1
| New | +$156 | ﹤0.01% | 6813 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6751 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6733 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6628 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6458 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6621 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6571 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6263 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6290 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6280 |
|
|
2017
Q3 | – | Sell |
-2
| Closed | -$12.4K | – | 6245 |
|
|
2017
Q2 | $13K | Hold |
2
| – | – | ﹤0.01% | 5723 |
|
|
2017
Q1 | $28K | Sell |
2
-1
| -33% | -$14.1K | ﹤0.01% | 5629 |
|
|
2016
Q4 | $40K | Hold |
3
| – | – | ﹤0.01% | 5444 |
|
|
2016
Q3 | $59K | Buy |
3
+2
| +200% | +$38.8K | ﹤0.01% | 5222 |
|
|
2016
Q2 | $16K | Hold |
1
| – | – | ﹤0.01% | 5548 |
|
|
2016
Q1 | $14K | Hold |
1
| – | – | ﹤0.01% | 5597 |
|
|
2015
Q4 | $14K | Buy |
+1
| New | +$16.3K | ﹤0.01% | 5665 |
|
Other funds holding TTNP
CA
GWSA
CSC
DJSG
Wells Fargo's TTNP Position: Q4 2025 in Review
Wells Fargo sold out of Titan Pharmaceuticals (TTNP) in Q4 2025, closing a stake of 1 share — an estimated $5 sold.
Wells Fargo first reported a position in TTNP in Q4 2015 and held it in 30 quarters. The position peaked at $59K in Q3 2016. 4 funds tracked by Wall St. Rank hold TTNP as of Q4 2025.
- Wells Fargo reported no remaining Titan Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Wells Fargo sold 1 Titan Pharmaceuticals share in Q4 2025, an estimated $5.
- Wells Fargo first reported a position in Titan Pharmaceuticals in Q4 2015 and held it in 30 quarters.
- Wells Fargo's Titan Pharmaceuticals position peaked at $59K in Q3 2016.
- 4 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2025.
Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.